Chiralpedia

CBS Reduction
Definition: Corey–Bakshi–Shibata borane reduction of ketones using chiral oxazaborolidines.
Context: Reliable route to enantioenriched alcohols.
Example: CBS reduction of aryl ketones.
Related Terms: Asymmetric Catalysis, Reduction.
Reference: Corey, JACS (1987).

Chelation Control
Definition: Metal coordination overrides Felkin preferences in carbonyl additions.
Context: Explains opposite selectivity in presence of Lewis acids or metals.
Example: Addition to α-alkoxy aldehydes with Mg²⁺.
Related Terms: Cram’s Rule, Felkin–Anh.
Reference: Reetz, Angew. Chem. (1974).

Chiral

Associated Concept: Achiral

Definition: A geometric property of a molecule or object that is not superimposable on its mirror image.
Context: Chirality is foundational in stereochemistry, determining whether enantiomers exist and influencing pharmacological activity.
Example: Hands are chiral objects; lactic acid has R- and S-enantiomers.
Related Terms: Enantiomer; Chiral Center; Stereoisomer.
Reference: IUPAC. Compendium of Chemical Terminology (IUPAC Gold Book), 2nd Edition, 1997 (updated 2019).

Chiral Auxiliary
Definition: Temporarily attached chiral unit to control stereochemistry of a transformation.
Context: Delivers high selectivity; removed to give target enantioenriched product.
Example: Evans oxazolidinone auxiliaries.
Related Terms: Chiral Pool, Asymmetric Catalysis.
Reference: Evans, JACS (1981).

Chiral Awareness
Definition: The explicit recognition and incorporation of chirality in thinking, language, experimental design, data handling, modeling, regulation, and decision-making. Chiral awareness involves treating stereoisomers-especially enantiomers and diastereomers-as distinct chemical entities with potentially different properties, activities, safety profiles, and biological outcomes.
Example: Correct specification of stereochemical configuration in names, drawings, and databases; Clear communication of stereochemistry in teaching, papers, labels, and reports; Discrimination between stereoisomers in experiments, analysis, and modelling consideration of stereoselective pharmacology, metabolism, and toxicity; Avoidance of "stereochemical collapse" in AI/ML representations and informatics.
Related terms: Chiral-aware (adjectival form); Chiral Literacy; Chiral Intelligence; Chiral Bias; Stereo-blindness; Stereo-sloppy.
References: Eliel, E. L., & Wilen, S. H. Stereochemistry of organic compounds. New York: Wiley (1994); Ariens, E. J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. European Journal of Clinical Pharmacology, 26, 663-668 (1984); Smith, S. W. Chiral toxicology: It's the same thing... only different. Toxicological Sciences, 110(1), 4-30 (2009).

Chiral Bioequivalence
Definition: Demonstration that enantiomer exposure (AUC, Cmax) is equivalent between products.
Context: Regulatory expectation for racemates and single-enantiomer generics.
Example: Bioequivalence of racemic vs reformulated enantiomer products.
Related Terms: Bioequivalence, FDA Chiral Policy.
Reference: FDA Guidance (2017); FDA 1992 Policy.

Chiral CE (Capillary Electrophoresis)
Definition: Electrophoretic separation with chiral selectors (e.g., cyclodextrins) in the buffer.
Context: High-efficiency analytical separations for enantiomers.
Example: CE of amino acid enantiomers.
Related Terms: Chiral HPLC, CSP.
Reference: Scriba, Electrophoresis (2003).

Chiral Center (Central Chirality)

Broader Concept: Chirality

Associated Concept: Axial Chirality

Definition: A tetrahedral atom (usually carbon) bonded to four different substituents.
Context: Creates enantiomeric pairs; critical for drug selectivity and metabolism.
Example: The α-carbon of lactic acid.
Related Terms: Stereocenter, Enantiomer.
Reference: IUPAC Gold Book.

Chiral Chromatography

Broader Concept: Chromatography

Associated Concept: Chiral Stationary Phase (CSP)

Narrower Concepts: Chiral HPLC | Chiral SFC | Chiral GC | Chiral Capillary Electrophoresis

Definition: Chiral chromatography is a chromatographic technique used to separate, identify, and quantify the individual enantiomers of chiral compounds. It exploits stereoselective interactions between the analyte and a chiral selector, typically incorporated into a chiral stationary phase (CSP) or, less commonly, a chiral mobile phase additive (CMPA), resulting in differential retention of enantiomers.
Context: Chiral chromatography is one of the most important analytical techniques in pharmaceutical research, drug development, quality control, and regulatory analysis. It enables the determination of enantiomeric purity, enantiomeric excess (ee), and stereochemical stability of chiral drugs and intermediates. Common chromatographic techniques include chiral HPLC, supercritical fluid chromatography (SFC), gas chromatography (GC), capillary electrophoresis (CE), and thin-layer chromatography (TLC) using chiral selectors. The choice of separation method depends on the physicochemical properties of the analyte, the chiral selector, and the analytical objective.
Example: The enantiomers of warfarin, ibuprofen, and propranolol can be resolved using polysaccharide-based chiral stationary phases in HPLC or SFC. Chiral chromatography is routinely employed to verify the enantiomeric purity of single-enantiomer pharmaceutical products and to monitor stereoselective synthesis.
Related Terms:
Chiral Separation, Chiral Stationary Phase (CSP), Chiral Selector, Chiral Mobile Phase Additive (CMPA), Enantiomeric Separation, Enantiomeric Excess (ee), Resolution (Rs), HPLC, SFC, Gas Chromatography, Capillary Electrophoresis.
Reference: Aboul-Enein, H. Y., & Ali, I. (2003). Chiral Separations by Liquid Chromatography and Related Technologies. Marcel Dekker, New York. Ahuja, S. (Ed.). (2000). Chiral Separations by Chromatography. Oxford University Press. Allenmark, S. (Ed.). (1991). Chromatographic Enantioseparation: Methods and Applications. Ellis Horwood. Francotte, E., & Lindner, W. (Eds.). (2006). Chirality in Drug Research. Wiley-VCH. Gubitz, G., & Schmid, M. G. (2008). Chiral separation principles in capillary electrophoresis. Journal of Chromatography A, 1204(2), 140-156. Okamoto, Y., & Yashima, E. (1998). Polysaccharide derivatives for chromatographic separation of enantiomers. Angewandte Chemie International Edition, 37(1-2), 102-119. Subramanian, G. (Ed.). (2008). Chiral Separation Techniques: A Practical Approach (3rd ed.). Wiley-VCH.
Key Distinction (recommended for Chiralpedia)
Chiral chromatography is an analytical or preparative separation technique that resolves enantiomers based on differential interactions with a chiral environment. It differs from chiral resolution, which is the broader process of obtaining individual enantiomers and may involve chromatographic, crystallization, enzymatic, or chemical methods.
Key Insight
Chiral chromatography has become the gold standard for enantiomeric analysis in the pharmaceutical industry, providing highly sensitive and reliable methods for assessing stereochemical purity, supporting regulatory compliance, and enabling the development of safer, more effective chiral medicines.

Chiral Derivatizing Agent (CDA)
Definition: Enantiomers are converted to diastereomers by reacting with a chiral reagent to enable separation.
Context: Facilitates NMR/LC analysis when direct separation is difficult.
Example: Mosher’s acid chloride (MTPA-Cl).
Related Terms: CDA, Chiral Solvating Agent.
Reference: Mosher, JACS (1973).

Chiral Drug
Definition: A pharmaceutical compound that contains one or more chiral centers or stereogenic elements, existing as enantiomers, diastereomers, or mixtures.
Context: Regulatory and therapeutic implications are critical; one enantiomer may be active (eutomer) while the other may be inactive or harmful (distomer).
Example: Ibuprofen (sold as a racemate, though only the S-enantiomer is pharmacologically active).
Related Terms: Enantiopure; Racemate; Eutomer; Distomer; Stereo-pharmacology.
Reference: FDA. Policy Statement for the Development of New Stereoisomeric Drugs (1992).

Chiral Education
Definition: The structured teaching and learning of chirality and stereochemistry, from fundamental spatial concepts to advanced applications in synthesis, biology, and medicine.
Context: Chiral education spans undergraduate instruction, professional training, and continuing education. Modern chiral education emphasizes three-dimensional thinking, molecular visualization, biological relevance, and translational impact, particularly in medicinal chemistry and pharmaceutical sciences.
Example: Teaching stereochemistry using molecular models and real drug case studies (e.g., thalidomide, ibuprofen, citalopram) rather than only abstract projections.
Related Terms: Chiral Literacy; Stereochemistry; Medicinal Chemistry; Stereo-pharmacology, Chiral Pharmacology
Reference: Holme, T. A. Assessing conceptual understanding in stereochemistry. Journal of Chemical Education, 96, 401-410 (2019); Nicoll, G. Investigating student misconceptions in organic chemistry: Stereochemistry and representations. Journal of Chemical Education, 78, 623-627 (2001); Clement, J., & Ainsworth, S. Multiple visual representations in chemistry learning. Topics in Cognitive Science, 10, 857-874 (2018); Underwood, S. M., et al. Expert-novice differences in interpreting stereochemical representations. Journal of Chemical Education, 93, 2014-2021 (2016).

Chiral Fidelity
Definition: The degree to which stereochemical integrity is preserved throughout molecular design, synthesis, analysis, formulation, storage, and biological evaluation.
Context: Chiral fidelity reflects how well a system maintains the intended configuration or enantiomeric composition without racemization, epimerization, or atropisomer interconversion. In pharmaceutical development, high chiral fidelity is essential for reproducibility, safety, and regulatory compliance across the product lifecycle.
Example: Demonstrating that an enantiopure API retains ?99% enantiomeric excess during scale-up, formulation, and shelf-life stability studies.
Related Terms: Enantiopure; Racemization; Stereomutation; Chiral Control; Stereochemical Stability
Reference: ICH Q6A. Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and Products (1999). Ariens, E. J., Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology, European Journal of Clinical Pharmacology, 26, 663-668 (1984). DOI: 10.1007/BF00541922 Demonstrates how maintaining or improving enantiomeric integrity alters clinical outcomes - a practical expression of chiral fidelity.

Chiral GC (Gas Chromatography)
Definition: GC using chiral stationary phases for volatile enantiomers.
Context: Useful for small, volatile APIs and intermediates.
Example: Resolution of limonene enantiomers.
Related Terms: Chiral HPLC, CE.
Reference: Schurig & Nowotny, J. Chromatogr. A (1990).

Chiral HPLC
Definition: HPLC using chiral stationary phases to separate enantiomers.
Context: Workhorse analytical and preparative method in pharma.
Example: Separation of R/S-propranolol.
Related Terms: CSP, SFC.
Reference: Scriba, J. Chromatogr. A (2016).

Chiral Intelligence
Definition: The capacity to understand, interpret, and apply chirality-dependent information across chemical, biological, pharmacological, and regulatory domains.
Context: Chiral intelligence goes beyond recognizing stereochemical descriptors; it integrates molecular structure, biological response, metabolism, safety, and lifecycle decision-making. In pharmaceutical development, chiral intelligence underpins decisions on enantiomer selection, analytical control, regulatory strategy, and clinical risk assessment.
Example: Recognizing that only S-ibuprofen is pharmacologically active, while R-ibuprofen undergoes partial in vivo inversion, and integrating this knowledge into dosing, formulation, and regulatory justification.
Related Terms: Chiral Literacy; Stereo-pharmacology; Eudismic Ratio; Enantiopure; Chiral Drug, Stereochemistry-Aware Models; Enantiomeric Specificity.
Reference: Ariens, E. J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Medical Research Reviews, 4, 197-236 (1984); Jorner, K., Yu, E., Yoshikawa, N., Jorner, K., Aspuru-Guzik, A., et al. Stereochemistry-aware string-based molecular generation. PNAS Nexus, 4(11), pgaf329 (2025); Reymond, J.-L. Stereochemistry in chemoinformatics and artificial intelligence. Accounts of Chemical Research, 55, 2210-2220 (2022).

Chiral Inversion
Definition: In vivo conversion of one enantiomer to the other.
Context: Impacts dosing and exposure; must be characterized in PK.
Example: R-ibuprofen inverts to S-ibuprofen in humans.
Related Terms: Stereopharmacology, Metabolism.
Reference: Hutt & Caldwell, J. Pharm. Pharmacol. (1983).

Chiral Ligand
Definition: A ligand that induces asymmetry in metal-catalyzed reactions.
Context: Central in enantioselective hydrogenation and C–C bond formation.
Example: BINAP ligand.
Related Terms: Asymmetric Catalysis, Enantioselectivity.
Reference: Noyori, Angew. Chem. (1994).

Chiral Literacy
Definition: The foundational ability to read, interpret, and correctly use stereochemical language, representations, and concepts in chemistry and life sciences.
Context: Chiral literacy includes competence with R/S, E/Z, D/L, wedge-dash notation, projections (Fischer, Newman), and stereochemical terminology. It is essential for clear scientific communication, avoidance of stereochemical errors, and proper interpretation of literature, patents, and regulatory documents.
Example: Correctly distinguishing between D/L nomenclature (relative configuration) and d/l optical rotation, avoiding the common misconception that they are equivalent.
Related Terms: Chiral Education; Stereochemistry; Configuration; Stereoisomers, Stereochemical Notation; Spatial Reasoning; Asymmetric Synthesis.
Reference: Eliel, E. L., Wilen, S. H., & Mander, L. N. (1994). Stereochemistry of Organic Compounds. Wiley; Clayden, J., Greeves, N., & Warren, S. (2021). Organic Chemistry (2nd ed.). Oxford University Press; Kociok-Kohn, G. Chirality and its importance in chemistry and biology. Angewandte Chemie International Edition, 57, 10956-10958 (2018); Fallen, B., et al. Students' difficulties with chirality and stereochemical reasoning: A review. Chemistry Education Research and Practice, 21, 307-323 (2020).

Chiral Mass Spectrometry
Definition: MS technique combined with chiral derivatization or ion mobility to distinguish enantiomers.
Context: Emerging analytical tool for stereoisomers.
Example: Chiral recognition of amino acids.
Related Terms: MS, Chiral Derivatizing Agents.
Reference: Dwivedi et al., Anal Chem (2006).

Chiral Materials
Definition: Materials that possess intrinsic or emergent chirality arising from molecular structure, supramolecular organization, crystallographic arrangement, nanoscale architecture, or hierarchical assembly, resulting in non-superimposable mirror-image forms and chirality-dependent physical, chemical, optical, electronic, or biological properties.
Context: Chiral materials extend chirality beyond individual molecules into functional materials science, where stereochemical organization influences bulk behavior. Chirality may arise from: Molecular chirality (chiral monomers, polymers, ligands); Supramolecular chirality (self-assembled helices, liquid crystals); Crystallographic chirality (chiral crystal packing); Topological chirality (knots, catenanes); Helical chirality (helical polymers, helicenes); Nanostructural chirality (chiral nanoparticles, plasmonic systems); Chiral materials are increasingly important in: Enantioselective catalysis; Chiral separations; Optical materials; Circularly polarized luminescence (CPL); Spintronics and Chiral-Induced Spin Selectivity (CISS); Biosensing; Drug delivery systems; Molecular electronics; Peptide and biomaterials engineering; Soft matter and liquid crystal technologies. The emergence of chirality at multiple length scales can produce amplified stereochemical effects, where local molecular asymmetry propagates into macroscopic material behavior.
Example: Helical polyacetylene derivatives exhibiting circular dichroism; Chiral metal-organic frameworks (MOFs) used for enantioselective separations; DNA-templated nanomaterials displaying chirality-dependent optical responses; Peptide self-assemblies forming chiral nanofibers Related Terms: Chirality; Homochirality; Chiral Recognition; Circular Dichroism; Chiral-Induced Spin Selectivity; Helicity; Supramolecular Chirality; Topological Chirality
Reference: Green, M. M.; Park, J.-W.; Sato, T.; Teramoto, A.; Lifson, S.; Selinger, R. L. B.; Selinger, J. V. The Macromolecular Route to Chiral Amplification. Angewandte Chemie International Edition, 38, 3138-3154 (1999). Naaman, R.; Waldeck, D. H. Chiral-Induced Spin Selectivity Effect. Annual Review of Physical Chemistry, 66, 263-281 (2015). Yashima, E.; Maeda, K.; Iida, H.; Furusho, Y.; Nagai, K. Helical Polymers: Synthesis, Structures, and Functions. Chemical Reviews, 109, 6102-6211 (2009).

Chiral Pharmacology
Definition: Chiral pharmacology is the branch of pharmacology that studies how molecular chirality influences the pharmacological behavior of drugs. It examines the stereoselective differences between enantiomers in terms of pharmacodynamics, pharmacokinetics, metabolism, therapeutic efficacy, toxicity, and clinical outcomes.
Context: Most biological macromolecules-including receptors, enzymes, ion channels, transport proteins, and nucleic acids-are inherently chiral. Consequently, individual enantiomers of a chiral drug often interact differently with these biological targets, leading to distinct pharmacological and toxicological profiles. Chiral pharmacology provides the scientific basis for understanding these stereoselective interactions and supports the rational design, development, regulatory evaluation, and clinical use of single-enantiomer drugs.
Example: Esomeprazole, the (S)-enantiomer of omeprazole, exhibits improved pharmacokinetic properties and more consistent acid suppression than the racemic formulation. Likewise, levobupivacaine demonstrates reduced cardiotoxicity compared with racemic bupivacaine, illustrating the clinical significance of chiral pharmacology.
Broader Concept: Stereopharmacology
Associated Concept: Chiral Drug
Narrower Concept: Chiral Pharmacodynamics; Chiral Pharmacokinetics
Related Terms: Chirality, Stereochemistry, Enantiomer, Chiral Drug, Stereoselectivity, Chiral Pharmacodynamics, Chiral Pharmacokinetics, Eutomer, Distomer, Chiral Switch.
Reference: Hutt, A. J., & Caldwell, J. (1985). The importance of stereochemistry in drug action and disposition. Pharmacology & Therapeutics, 29(2), 245-263. Caldwell, J. (1995). Chiral pharmacology and the regulation of new drugs. Chemistry and Industry, 6, 176-179. Ariens, E. J. (1984). Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. European Journal of Clinical Pharmacology, 26, 663-668. Agranat, I., Caner, H., & Caldwell, J. (2002). Putting chirality to work: The strategy of chiral switches. Nature Reviews Drug Discovery, 1(10), 753-768. Nguyen, L. A., He, H., & Pham-Huy, C. (2006). Chiral Drugs: An Overview. International Journal of Biomedical Science, 2(2), 85-100. Smith, S. W. (2009). Chiral Toxicology: It's the Same Thing... Only Different. Toxicological Sciences, 110(1), 4-30.

Chiral Phosphate Catalysis
Definition: Brønsted acid catalysis using BINOL-derived chiral phosphoric acids.
Context: Broad platform for enantioselective additions and rearrangements.
Example: CPA-catalyzed Mannich reactions.
Related Terms: Organocatalysis, Brønsted Acid Catalysis.
Reference: Akiyama/Terada, Chem. Rev. (2018).

Chiral Photochemistry
Definition: Use of light to induce stereocontrol via chiral catalysts, templates, or circularly polarized light.
Context: Enables unique selectivity pathways and deracemization.
Example: CPL-mediated enantioenrichment.
Related Terms: Asymmetric Catalysis, CPL.
Reference: Bach & Hehn, Angew. Chem. (2011).

Chiral Pool Synthesis
Definition: Use of abundant natural enantiopure building blocks as stereochemical sources.
Context: Efficient, scalable strategy in pharmaceutical synthesis.
Example: Use of L-amino acids to set stereochemistry.
Related Terms: Biocatalysis, Chiral Auxiliary.
Reference: Morrison & Boyd.

Chiral Quantum Dots (CQDs)
Definition: Quantum dots that possess intrinsic or induced chirality, resulting in stereochemically dependent optical, electronic, spin-selective, or biological properties. Chirality in quantum dots may arise from chiral ligands, asymmetric surface organization, chiral crystal structures, supramolecular assembly, or nanoscale morphology, producing distinguishable left- and right-handed nanosystems.
Context: Quantum dots are semiconductor nanocrystals exhibiting size-dependent quantum confinement effects. When chirality is incorporated, these nanomaterials acquire additional stereochemical functionality, enabling interactions with circularly polarized light, chiral biomolecules, and spin-polarized electronic systems. Chiral quantum dots represent an emerging interface between: Nanotechnology; Chiral materials science; Quantum photonics; Bioimaging; Enantioselective sensing; Spintronics; Molecular recognition; Quantum information science; Chiral optoelectronics Chirality may be introduced through: Intrinsic chirality; Chiral crystal lattice; Organization Morphological asymmetry; Surface-induced chirality; Chiral ligand capping; Amino acid functionalization; Peptide-directed assembly; Assembly-derived chirality; Helical nanoparticle organization; Supramolecular chiral ordering. Chiral quantum dots frequently exhibit: Circular Dichroism (CD); Circularly Polarized Luminescence (CPL); Enantioselective recognition; Chiral-Induced Spin Selectivity (CISS)-related effects; Optical activity at nanoscale dimensions Their stereochemical behavior makes them particularly interesting for next-generation biosensors, imaging agents, and quantum materials.
Example: Cadmium selenide quantum dots functionalized with L-cysteine or D-cysteine displaying chirality-dependent optical signatures, Peptide-capped quantum dots exhibiting stereoselective interactions with biological targets.
Related Terms: Chiral Materials; Circular Dichroism; Circularly Polarized Luminescence; Chiral-Induced Spin Selectivity; Helical Chirality; Chiral Nanomaterials; Quantum Confinement
Reference: Ben-Moshe, A.; Teitelboim, A.; Oron, D.; Markovich, G. Probing the Chiroptical Properties of Semiconductor Nanocrystals Using Circular Dichroism Spectroscopy. Nano Letters, 16, 7467-7473 (2016). Ma, W.; Xu, L.; Wang, L.; Xu, C.; Kuang, H. Chiral Inorganic Nanostructures. Chemical Society Reviews, 48, 2936-2954 (2019). Naaman, R.; Waldeck, D. H. Chiral-Induced Spin Selectivity Effect. Annual Review of Physical Chemistry, 66, 263-281 (2015).

Chiral Recognition
Definition: Selective interaction of a host with one enantiomer over the other.
Context: Underlies chiral separations and receptor binding selectivity.
Example: Cyclodextrin inclusion complexes.
Related Terms: Molecular Imprinting, Chiral HPLC.
Reference: Wainer, Drug Discov Today (1997).

Chiral Resolution by Enzymes
Definition: Use of biocatalysts to selectively transform one enantiomer.
Context: Scalable, green alternative to chemical resolution.
Example: Lipase-catalyzed ester hydrolysis.
Related Terms: Biocatalysis, Kinetic Resolution.
Reference: Bornscheuer, Nature (2012).

Chiral Separation

Associated Concept: Asymmetric Synthesis

Broader Concept: Separation Science


Definition: The process of separating the individual enantiomers of a chiral compound from a racemic mixture or an enantioenriched mixture to obtain one or both enantiomers in high optical purity.
Context: Chiral separation is a fundamental technique in pharmaceutical, agrochemical, and fine chemical industries because enantiomers often differ in their pharmacological, toxicological, and physicochemical properties. Separation may be achieved by direct methods, such as chiral chromatography using a chiral stationary phase, or indirect methods, such as derivatization with a chiral reagent to form diastereomers followed by conventional separation. Chiral separation plays a critical role in drug discovery, quality control, regulatory compliance, and the production of enantiopure compounds.
Example: The enantiomers of warfarin can be separated by chiral high-performance liquid chromatography (HPLC) using a chiral stationary phase, allowing independent evaluation of their pharmacokinetic and pharmacodynamic properties.
Related Terms: Chiral Resolution, Racemate, Enantiopure, Enantioenriched, Chiral Chromatography, Chiral Stationary Phase (CSP), Kinetic Resolution.
Reference: Ahuja, S. (Ed.). (1997). Chiral Separations by Chromatography. American Chemical Society, ACS Symposium Series 471; Ahuja, S. (2000). Chiral Separation Methods for Pharmaceutical and Biotechnological Products. John Wiley & Sons. ISBN: 978-0471370308; Gubitz, G., & Schmid, M. G. (2008). Chiral Separation Principles in Capillary Electrophoresis. Journal of Chromatography A, 1204, 140-156; Ward, T. J., & Ward, K. D. (2012). "Chiral Separations: A Review of Current Topics and Trends." Analytical Chemistry, 84, 626-635; International Union of Pure and Applied Chemistry. Compendium of Chemical Terminology (Gold Book) - Entries on enantiomer separation and chromatographic terminology.
Key Distinction
Chiral Separation: The general process of separating enantiomers by any physical, chemical, or biological method.
Chiral Resolution: A specific type of chiral separation in which a racemate is resolved into its constituent enantiomers.
Direct Chiral Separation: Uses a chiral environment (e.g., chiral stationary phase, chiral selector, chiral mobile-phase additive) to discriminate between enantiomers.
Indirect Chiral Separation: Converts enantiomers into diastereomers using a chiral derivatizing or resolving agent, followed by separation using conventional techniques.
Key Insight:
Chiral separation encompasses all techniques used to isolate individual enantiomers, whereas chiral resolution specifically refers to the separation of a racemic mixture. Thus, every chiral resolution is a chiral separation, but not every chiral separation is a chiral resolution. This distinction is especially relevant in pharmaceutical manufacturing, where both analytical and preparative chiral separations are essential for ensuring the quality, efficacy, and safety of chiral drugs.

Chiral SFC (Supercritical Fluid Chromatography)
Definition: Chromatography using supercritical CO₂ with chiral stationary phases.
Context: Fast, green separations widely adopted for enantioresolution.
Example: Rapid enantiomer separation of β-blockers.
Related Terms: Chiral HPLC, CSP.
Reference: Berger, Supercritical Fluid Chromatography (1995).

Chiral Shift Reagent
Definition: Paramagnetic lanthanide complexes that induce differential NMR shifts for enantiomers.
Context: Legacy technique for stereochemical analysis.
Example: Eu(fod)₃ added to racemates.
Related Terms: CSA, NMR.
Reference: Günther, NMR Spectroscopy (2013).

Chiral Solvating Agent (CSA)
Definition: Chiral additive forming diastereomeric complexes that resolve NMR signals.
Context: Allows ee determination without derivatization.
Example: Pirkle’s alcohols; TFAE.
Related Terms: CDA, NMR.
Reference: Pirkle, J. Org. Chem. (1967).

Chiral Stationary Phase (CSP)
Definition: Chromatographic phase containing chiral selectors (polysaccharides, cyclodextrins, Pirkle-type, proteins).
Context: Core technology for analytical and preparative enantioseparation.
Example: Cellulose tris(3,5-dimethylphenylcarbamate).
Related Terms: Chiral HPLC, SFC.
Reference: Scriba, J. Chromatogr. A (2016).

Chiral Switch

Associated Concept: Racemic Drug

Definition: Replacing a racemic drug with its single active enantiomer.
Context: Lifecycle and safety strategy improving efficacy and dose control.
Example: Esomeprazole replacing omeprazole.
Related Terms: Eutomer, Stereopharmacology.
Reference: FDA Policy (1992).

Chiral Toxicology
Definition: Study of enantioselective toxicity and safety profiles.
Context: Eutomers and distomers can differ in adverse effects; regulators expect isomer-specific assessment.
Example: S-thalidomide vs R-thalidomide.
Related Terms: Eutomer, Distomer.
Reference: FDA Stereoisomeric Drugs Policy (1992).

Chiral-First Design
Definition: A molecular design philosophy in which chirality is considered a primary design parameter from the earliest stages of discovery, rather than an afterthought addressed during optimization or development.
Context: Chiral-first design integrates stereochemistry into target selection, ligand design, synthesis planning, and biological evaluation. This approach reduces downstream risk, avoids late-stage chiral switches, and improves alignment between chemical structure and biological function.
Example: Designing a kinase inhibitor library around a defined axial chirality scaffold instead of screening racemic mixtures and resolving later.
Related Terms: Chiral Intelligence; Stereo-pharmacology; Enantioselective Synthesis; Drug Design Strategy
Reference: Ariens, E. J., Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology, European Journal of Clinical Pharmacology, 26, 663-668, (1984) DOI: 10.1007/BF00541922
FDA Guidance for Industry (1992) Development of New Stereoisomeric Drugs
Establishes the requirement to maintain, characterize, and justify stereochemical integrity throughout development - a direct institutional basis for chiral fidelity.

Chiral-Induced Spin Selectivity (CISS)
Definition: Phenomenon where electron spin polarization arises during transport through chiral media.
Context: Emerging relevance in bioelectronics and sensing; conceptual interest in drug–protein interactions.
Example: Spin filtering through DNA helices.
Related Terms: Helicity, Chiroptics.
Reference: Naaman & Waldeck, Annu. Rev. Phys. Chem. (2015).

Chirality

Broader Concept: Stereochemistry

Narrower Concepts: Point Chirality | Axial Chirality | Planar Chirality | Helical Chirality

Definition: The geometric property of an object or molecule that renders it non-superimposable on its mirror image. A chiral molecule and its mirror image exist as a pair of stereoisomers called enantiomers.
Synonyms: Molecular Handedness; Handedness (informal).
Context: Chirality is a fundamental concept in stereochemistry and plays a crucial role in chemistry, biology, pharmacology, agrochemistry, materials science, and molecular recognition. Because biological systems are inherently chiral, the two enantiomers of a chiral molecule may exhibit different pharmacological, toxicological, sensory, or environmental properties. Chirality can arise from a stereogenic center, axis, plane, helix, or other stereogenic elements.
Example: The two enantiomers of lactic acid are mirror images that cannot be superimposed on one another. Likewise, a person's left and right hands are macroscopic examples of chirality.
Related Terms: Chiral Molecule, Achiral Molecule, Enantiomer, Stereochemistry, Stereogenic Center, Axial Chirality, Planar Chirality, Helical Chirality.
Reference: International Union of Pure and Applied Chemistry. Compendium of Chemical Terminology (Gold Book): Chirality; Eliel, E. L., Wilen, S. H., & Doyle, M. P. (1994). Basic Organic Stereochemistry. John Wiley & Sons. ISBN: 978-0471374993; Clayden, J., Greeves, N., & Warren, S. (2012). Organic Chemistry (2nd ed.). Oxford University Press. ISBN: 978-0199270294; Morrison, R. T., & Boyd, R. N. (1992). Organic Chemistry (6th ed.). Prentice Hall, Englewood Cliffs, NJ. ISBN: 978-0136436691.
Key Distinction
Chiral: Non-superimposable on its mirror image.
Achiral: Superimposable on its mirror image.
Chirality: The property of being chiral.
Enantiomers: A pair of non-superimposable mirror-image stereoisomers resulting from chirality. Key Insight: Chirality is often described as "molecular handedness." Just as left and right hands are mirror images that cannot be perfectly overlaid, chiral molecules exist in mirror-image forms that may exhibit profoundly different behavior in biological and chemical systems. This phenomenon underpins the importance of stereochemistry in modern science and medicine.

Chirality (Chiral) Cliff

Associated Concept: Activity Cliff

Broader Concept: Activity Cliff

Definition: A phenomenon in which a small stereochemical change-typically a change in molecular chirality or stereochemical configuration-produces a disproportionately large change in biological, physicochemical, or pharmacological properties. A chirality cliff is the stereochemical analogue of an activity cliff in medicinal chemistry.
Synonyms: Stereochemical Cliff (less common); Chiral Activity Cliff (context-specific).
Context: Chirality cliffs arise because biological targets are inherently chiral and can discriminate sharply between stereoisomers. Consequently, two enantiomers or closely related stereoisomers that differ only in stereochemistry may exhibit dramatic differences in receptor binding, potency, selectivity, metabolism, toxicity, or pharmacokinetic behavior. Recognizing chirality cliffs is important in medicinal chemistry, drug discovery, QSAR modeling, molecular docking, and AI-driven molecular design, where neglecting stereochemistry can lead to inaccurate predictions.
Example: The enantiomers of thalidomide exhibit markedly different biological effects, illustrating a profound chirality cliff. Likewise, the two enantiomers of penicillamine differ substantially in therapeutic activity and toxicity despite differing only in stereochemistry.
Related Terms: Activity Cliff, Chirality, Enantiomer, Stereochemistry, Chiral Switch, Eutomer, Distomer, Stereoselectivity.
Reference: Stumpfe D, Hu H, Bajorath J. Evolving Concept of Activity Cliffs. ACS Omega. 2019 Aug 26;4(11):14360-14368. doi: 10.1021/acsomega.9b02221.
Dr. Vijay Masand, Mr. Gaurav Masand, Dr. Sami A. Al-Hussain, Dr. Rahul Jawarkar, Dr. Vesna Rastija 0000-0001-9542-4022, and Dr. Magdi E.A. ZakiA. PyDescriptorC*: A Descriptor Calculation Tool for Decoding Chirality Cliffs and Revealing Hidden Patterns in Drug Discovery, 2025. https://doi.org/10.26434/chemrxiv-2025-w3k4n
Vijay H. Masand, Mithilesh M. Rathore, Sami A. Al-Hussain, Abdullah Y.A. Alzahrani, Sumer D. Thakur, Abdul Samad, Magdi E.A. Zaki. Journal of Molecular Graphics and Modelling. 2026. https://doi.org/10.1016/j.jmgm.2026.109515
Key Distinction
Activity Cliff: A small structural modification produces a large change in biological activity. Chirality Cliff: A special type of activity cliff in which the stereochemical difference alone is responsible for the dramatic change in properties. Chiral Switch: Development of a single-enantiomer drug from a racemic drug based, in part, on differences that may reflect a chirality cliff. Eutomer/Distomer: Describe the more active and less active enantiomers, whereas a chirality cliff emphasizes the magnitude of the difference between them.
Key Insight
A chirality cliff highlights the fact that mirror-image molecules are not necessarily biologically equivalent. Even when two molecules have identical molecular formulas and connectivity, a change only in stereochemistry can result in profound differences in efficacy, selectivity, metabolism, or toxicity. The concept underscores the importance of explicitly considering chirality in drug design, molecular modeling, and regulatory evaluation.
Editorial Note for Chiralpedia:

CIP Rules
Definition: Priority rules to rank substituents for stereochemical assignment.
Context: Foundation for R/S and E/Z nomenclature across industry and regulation.
Example: Assigning R to lactic acid’s chiral center.
Related Terms: R/S Configuration, E/Z Isomerism.
Reference: Cahn, Ingold & Prelog, Experientia (1956).

Circular Dichroism (CD)
Definition: Difference in absorption of left vs right circularly polarized light.
Context: Key chiroptical method for absolute configuration and secondary structure.
Example: ECD of helicenes; protein far-UV CD.
Related Terms: ECD, VCD, ROA.
Reference: Kelly et al., Biochim. Biophys. Acta (2005).

Circularly Polarized Luminescence (CPL)
Definition: Difference in emission of left vs right circularly polarized light.
Context: Emerging tool for chiral luminophores and bioimaging probes.
Example: CPL of lanthanide complexes.
Related Terms: CD, g-factor.
Reference: Zinna & Di Bari, Chirality (2015).

Configuration

Associated Concept: Conformation

Definition: The fixed spatial arrangement of atoms about a stereogenic element not interconverted without bond breaking.
Context: Configuration defines absolute identity of stereoisomers and must be controlled in pharma.
Example: R vs S configuration at a chiral center.
Related Terms: Absolute Configuration, Relative Configuration.
Reference: IUPAC Gold Book.

Conformation

Associated Concept: Configuration

Definition: Different spatial arrangements generated by rotation about single bonds.
Context: Bioactive conformation often dictates receptor binding and SAR.
Example: Anti vs gauche conformers of butane.
Related Terms: Conformational Isomerism, Bioactive Conformation.
Reference: Clayden et al., Organic Chemistry (2012).

Conformational Constraint
Definition: Structural modification limiting molecular flexibility.
Context: Improves binding affinity and selectivity.
Example: Locked nucleic acids (LNAs).
Related Terms: SAR, Pharmacophore.
Reference: Silverman, Drug Design (2014).

Conformational Isomer (Conformer)
Definition: Isomers differing only by rotation about single σ-bonds without bond breaking.
Context: Conformational analysis is essential in understanding stability, reactivity, and bioactive geometry.
Example: Chair and boat forms of cyclohexane.
Related Terms: Conformer; Conformation; Eclipsed; Gauche.
Reference: Clayden, J., Greeves, N., Warren, S. & Wothers, P. Organic Chemistry. Oxford University Press, 2012.

Conformational Isomerism

Associated Concept: Atropisomerism

Definition: Interconversion between isomers via rotation about σ-bonds.
Context: Conformational preferences control stereochemical outcomes and binding.
Example: Chair vs boat cyclohexane.
Related Terms: Conformation, Stereoelectronic Effect.
Reference: Clayden et al. (2012).

Conformer
Definition: A specific spatial arrangement of atoms in a molecule that can be interconverted by rotation about single bonds.
Context: Conformers represent energetically accessible geometries; populations depend on steric and electronic effects.
Example: Staggered and eclipsed conformations of ethane.
Related Terms: Conformational Isomer; Newman Projection; Gauche; Eclipsed.
Reference: Eliel, E. L. & Wilen, S. H. Stereochemistry of Organic Compounds. Wiley, 1994.

Conglomerate (Racemic Conglomerate)
Definition: Racemic mixture that crystallizes as separate enantiomorphic crystals.
Context: Enables preferential crystallization and Viedma ripening strategies.
Example: Sodium ammonium tartrate behavior.
Related Terms: Racemate, Viedma Ripening.
Reference: Eliel & Wilen (1994).

Cornforth Model
Definition: Predicts anti-selective substitution via antiperiplanar alignment.
Context: Used for 1,3-asymmetric induction analysis.
Example: Allylic substitutions.
Related Terms: Felkin–Anh, Zimmerman–Traxler.
Reference: Cornforth, Chem. Soc. Rev. (1971).

Cotton Effect
Definition: Characteristic sign and magnitude change in CD/ORD near an absorption band.
Context: Diagnostic for electronic transitions and stereochemical assignment.
Example: Positive/negative couplets in aromatic chromophores.
Related Terms: CD, ORD, Exciton Coupling.
Reference: Nakanishi et al. (2007).

Cram’s Rule
Definition: Predicts diastereofacial selectivity based on minimizing steric interactions.
Context: Competes with chelation control in carbonyl additions.
Example: Nucleophile addition to chiral ketones.
Related Terms: Felkin–Anh, Chelation Control.
Reference: Cram, JACS (1952).

Curtin–Hammett Principle
Definition: Product distribution is determined by transition-state energies when conformers interconvert faster than they react.
Context: Explains selectivity in conformationally flexible systems.
Example: Axial/equatorial conformers leading to different products.
Related Terms: Conformation, Kinetics.
Reference: Seeman, Chem. Rev. (1983).

Cyclodextrin CSP
Definition: Cyclodextrin-based selectors suitable for polar and volatile analytes.
Context: Common in CE and GC for small molecules.
Example: β-Cyclodextrin phases.
Related Terms: CSP, Chiral CE/GC.
Reference: Scriba (2003/2016).